The injection itself takes less than five minutes
Peptide therapy is generally well-tolerated, with minimal side effects
Protocol 1: Conservative foundation (beginners) Goal: Gentle immune modulation with minimal risk Components: Thymosin alpha-1: 1.6 mg subcutaneously, twice weekly BPC-157: 250 mcg subcutaneously, once daily (abdominal injection for gut support) Schedule: Monday and Thursday: Thymosin alpha-1 Daily: BPC-157 in the morning Duration: 8 weeks on, 4 weeks off Monitoring: Baseline labs before starting, repeat at week 4 and week 8
GLP-1 has been shown to inhibit RAGE and decrease inflammation in human retinal pigment epithelium [137]
This comprehensive mechanism helps regulate appetite, promote fat oxidation, and support healthy metabolic function
Research Applications & Usage Information Musculoskeletal and Orthopedic Models: BPC-157 is used in studies on tendon, ligament, and muscle injuries in animals